Bank of New York Mellon
BBC icon

Bank of New York Mellon’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Bank of New York Mellon’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,800
Closed -$207K – 4113
2020
Q2 		$207K Buy
+4,800
New +$184K ﹤0.01% 3789

Other funds holding BBC

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FEM
Fulcrum Equity Management Plano, Texas $136M AUM 42.95% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of New York Mellon's BBC Position: Q3 2020 in Review

Bank of New York Mellon sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q3 2020, closing a stake of 4,800 shares — an estimated $207K sold.

Bank of New York Mellon first reported a position in BBC in Q2 2020 and held it in 1 quarter. The position peaked at $207K in Q2 2020. 18 funds tracked by Wall St. Rank hold BBC as of Q3 2020.

  • Bank of New York Mellon reported no remaining Virtus Biotech Clinical Trials ETF position as of Q3 2020 after selling out during the quarter.
  • Bank of New York Mellon sold 4,800 Virtus Biotech Clinical Trials ETF shares in Q3 2020, an estimated $207K.
  • Bank of New York Mellon first reported a position in Virtus Biotech Clinical Trials ETF in Q2 2020 and held it in 1 quarter.
  • Bank of New York Mellon's Virtus Biotech Clinical Trials ETF position peaked at $207K in Q2 2020.
  • 18 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2020.

Based on Bank of New York Mellon's 13F filing for Q3 2020, filed 12 Nov 2020.